Skip to main content
Equibles
ANIX logo

ANIX · Anixa Biosciences Inc · Metrics

Track ANIX — free

Use ANIX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ANIX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$3.18 +0.15 (+4.79%) At close · Nov 6
Rebalance outlook locked
Market Cap
$110.38M
Shares
34.76M
Volume · Nov 6 121.65K Avg daily vol (3M) 277.39K

ANIX metrics

71 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$3.18
Market cap
$105.33M

Price action

23 metrics
Price change (1W)
-8.2%
Price change (30D)
+2.7%
Price change (3M)
-11.7%
Price change (6M)
+2.4%
Price change (YTD)
-2.9%
Price change (1Y)
-25.6%
Trailing year
Price change (5Y)
-39.2%
52-week high
$5.22
52-week low
$2.35
Change from 52-week high
-42.0%
Change from 52-week low
+28.9%
Annualized volatility
66.7%
Annualized volatility (3M)
62.4%
Implied volatility (30D)
—
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
1.6
RSI (14D)
51.3
Price vs SMA 50
+3.5%
Price vs SMA 200
+2.2%
Avg volume (3M)
277,160
Relative volume
0.7
Average dollar volume
$842,633

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
34.76M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
7.3
reciprocal yield 13.7%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-9.9%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
—
Operating margin
-6,586.2%
Trailing 12 months
Net margin
-5,978.1%
Gross profit (TTM)
−$26,512
Operating profit (TTM)
−$10.98M
Net income (TTM)
−$10.38M
Trailing 12 months
Diluted EPS (TTM)
$-0.31
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
$0.00
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
$-0.98
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
$-0.28
Capital expenditures per diluted share (TTM)
$0.00
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$0.46

Growth

11 metrics
Revenue growth YoY
+0.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+5.3%
Year over year · more shares
Revenue CAGR (3Y)
-25.7%
Revenue CAGR (5Y)
-3.4%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-71.7%
Return on assets
-68.9%
Debt / equity
0.0
Current ratio
8.5
EBITDA (TTM)
−$18.56M
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$13.86M
Latest balance sheet
Cash & equivalents
$1.40M
Total assets
$15.07M
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$7.38M
Capital expenditures (TTM)
$15,791
R&D (TTM)
$4.83M
SG&A (TTM)
$4.90M
Stock compensation (TTM)
$2.90M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
66
13F filer change QoQ
+4
Institutional ownership
15.5%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
1.9%
Private-fund adviser ownership
1.8%
Active holders' share change QoQ
+8.3%
Holder tenure
10.7
Price vs estimated holder cost
-12.6%

Ownership (registered funds)

1 metrics
Index-fund ownership
5.0%

Short interest

3 metrics
Short interest
4.8%
Latest settlement · 6.4 days to cover
Days to cover
6.4d
Short-squeeze score
73 / 100

Insider activity

2 metrics
Net insider buying (90D)
$291,587
Insider-sentiment score
92 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 715446 CUSIP 03528H109 13F (30d) 25 filings 25 filers Visit website Investor relations